Veristat's independent Data Monitoring Committee (DMC) expertise offers unparalleled precision in data analysis and reporting, ensuring the safety, scientific validity, and integrity of clinical trials. Aligned with FDA guidance on the establishment and operation of clinical trial DMCs, DMCs are essential for clinical trials with significant safety concerns, risks, or complexities, providing independent assessment to protect current and future patients.
Independent Oversight for Critical Trial Decisions
By partnering with Veristat, sponsors can trust that their clinical trials are conducted with the highest patient safety and data integrity standards. Our dedication to protecting patients and delivering precise, reliable data analysis ensures that trial outcomes are robust and actionable. When seeking specialized, independent data oversight separate from your CRO activities, trust the unmatched biostatistical foundation of Veristat’s DMC experts.
How It Works
Every DMC starts the same way, with the right people, the right charter, and a process built for independence.
Identify.
We identify the relevant thought leaders for your committee.
Charter.
We draft the Committee Charter that governs how the DMC operates.
Coordinate.
We coordinate committee meetings and facilitate communications throughout.
Analyze.
We provide independent clinical trial data analysis, separate from your CRO's activities.
Report.
We write meeting minutes, generate patient safety reports, and manage safety and efficacy recommendations, including adaptive design modifications.
Veristat Expertise in Strategic Consulting
Proven DMC Expertise for Complex Trials
Expert Biostatistical Foundation
Extensive biostatistical expertise assures unparalleled precision in data analysis and reporting, crucial for independent DMC activities.
Enhanced Reporting Standards
Superior statistical reporting includes executive summaries with hyperlinked, detailed tables and visual data presentations, making complex data accessible and actionable.
Personalized, Tailored Expertise
DMC services built around each client's unique needs, distinct from large CROs that may not offer the same level of customization and attention.
Superior Organization and Communication
Meticulous planning and efficient management of DMC meetings, regulatory compliance, and documentation ensures a seamless, transparent experience.
Veristat's Offerings
Thought Leader Identification.
Identifying the relevant experts to serve on your committee.
Committee Charter Drafting.
Establishing the governing document your DMC operates under.
Meeting Coordination.
Coordinating committee meetings that facilitate communications.
Independent Data Analysis.
Providing independent clinical trial data analysis, separate from CRO activities.
Meeting Minutes.
Documenting committee proceedings accurately and thoroughly.
Patient Safety Reports.
Generating the safety reporting your DMC and regulators depend on.
Safety & Efficacy Recommendations.
Managing recommendations, including adaptive design modifications.
What's Next in the Drug Development Process
Biostatistics
Get the broader statistical planning and analysis behind your trial.
Adaptive Designs
Build the flexibility into your trial design that DMC recommendations may call for.
Clinical Trial Safety
Extend safety oversight into ongoing pharmacovigilance and aggregate safety reporting.
Related resources
Learn More with These Resources
Data-Driven Strategies to Advance Development and Approval of ...
Learn more →
Four Pillars of Success in Neurology Trials
Learn more →
Advancing Oncology Innovation
Learn more →
Know when the data calls for action.
As safety and efficacy data accumulates, the right interpretation can determine what happens next. Veristat’s independent DMC experts bring rigorous statistical analysis and experienced clinical judgment to the evidence, providing clear recommendations that inform critical trial decisions while protecting patient safety and study integrity.
A Data Monitoring Committee is an independent group that reviews accumulating clinical trial data to protect patient safety and ensure trial integrity, separate from the sponsor's or CRO's own trial activities.
Independence ensures unbiased oversight, DMC members and the analysis they rely on must be separate from the CRO's day-to-day trial activities to protect the objectivity of safety and efficacy recommendations.
Yes. Veristat's DMC services include managing safety and efficacy recommendations, including adaptive design modifications as trial data accumulates.
